Full Text of SB1684 99th General Assembly
SB1684enr 99TH GENERAL ASSEMBLY |
| | SB1684 Enrolled | | LRB099 10340 JLK 30567 b |
|
| 1 | | AN ACT concerning State government.
| 2 | | Be it enacted by the People of the State of Illinois,
| 3 | | represented in the General Assembly:
| 4 | | Section 5. The Department of Public Health Powers and | 5 | | Duties Law of the
Civil Administrative Code of Illinois is | 6 | | amended by adding Sections 2310-676 and 2310-677 as follows: | 7 | | (20 ILCS 2310/2310-676 new) | 8 | | Sec. 2310-676. Advisory council on pediatric autoimmune | 9 | | neuropsychiatric disorder associated with streptococcal | 10 | | infections and pediatric acute neuropsychiatric syndrome. | 11 | | (a) There is established an advisory council on pediatric | 12 | | autoimmune neuropsychiatric disorder associated with | 13 | | streptococcal infections and pediatric acute neuropsychiatric | 14 | | syndrome to advise the Director of Public Health on research, | 15 | | diagnosis, treatment, and education relating to the disorder | 16 | | and syndrome. | 17 | | (b) The advisory council shall consist of the following | 18 | | members, who shall be appointed by the Director of Public | 19 | | Health within 60 days after the effective date of this | 20 | | amendatory Act of the 99th General Assembly: | 21 | | (1) An immunologist licensed and practicing in this | 22 | | State who has experience treating persons with pediatric | 23 | | autoimmune neuropsychiatric disorder associated with |
| | | SB1684 Enrolled | - 2 - | LRB099 10340 JLK 30567 b |
|
| 1 | | streptococcal infections and pediatric acute | 2 | | neuropsychiatric syndrome and the use of intravenous | 3 | | immunoglobulin. | 4 | | (2) A health care provider licensed and practicing in | 5 | | this State who has expertise in treating persons with | 6 | | pediatric autoimmune neuropsychiatric disorder associated | 7 | | with streptococcal infections and pediatric acute | 8 | | neuropsychiatric syndrome and autism. | 9 | | (3) A representative of PANDAS/PANS Advocacy & | 10 | | Support. | 11 | | (4) An osteopathic physician licensed and practicing | 12 | | in this State who has experience treating persons with | 13 | | pediatric autoimmune neuropsychiatric disorder associated | 14 | | with streptococcal infections and pediatric acute | 15 | | neuropsychiatric syndrome. | 16 | | (5) A medical researcher with experience conducting | 17 | | research concerning pediatric autoimmune neuropsychiatric | 18 | | disorder associated with streptococcal infections, | 19 | | pediatric acute neuropsychiatric syndrome, | 20 | | obsessive-compulsive disorder, tic disorder, and other | 21 | | neurological disorders. | 22 | | (6) A certified dietitian-nutritionist practicing in | 23 | | this State who provides services to children with autism | 24 | | spectrum disorder, attention-deficit hyperactivity | 25 | | disorder, and other neuro-developmental conditions. | 26 | | (7) A representative of a professional organization in |
| | | SB1684 Enrolled | - 3 - | LRB099 10340 JLK 30567 b |
|
| 1 | | this State for school psychologists. | 2 | | (8) A child psychiatrist who has experience treating | 3 | | persons with pediatric autoimmune neuropsychiatric | 4 | | disorder associated with streptococcal infections and | 5 | | pediatric acute neuropsychiatric syndrome. | 6 | | (9) A representative of a professional organization in | 7 | | this State for school nurses. | 8 | | (10) A pediatrician who has experience treating | 9 | | persons with pediatric autoimmune neuropsychiatric | 10 | | disorder associated with streptococcal infections and | 11 | | pediatric acute neuropsychiatric syndrome. | 12 | | (11) A representative of an organization focused on | 13 | | autism. | 14 | | (12) A parent with a child who has been diagnosed with | 15 | | pediatric autoimmune neuropsychiatric disorder associated | 16 | | with streptococcal infections or pediatric acute | 17 | | neuropsychiatric syndrome and autism. | 18 | | (13) A social worker licensed and practicing in this | 19 | | State. | 20 | | (14) A representative of the Special Education | 21 | | Services division of the State Board of Education. | 22 | | (15) One member of the General Assembly appointed by | 23 | | the Speaker of the House of Representatives. | 24 | | (16) One member of the General Assembly appointed by | 25 | | the President of the Senate. | 26 | | (17) One member of the General Assembly appointed by |
| | | SB1684 Enrolled | - 4 - | LRB099 10340 JLK 30567 b |
|
| 1 | | the Minority Leader of the House of Representatives. | 2 | | (18) One member of the General Assembly appointed by | 3 | | the Minority Leader of the Senate. | 4 | | (c) The Director of Public Health, or his or her designee, | 5 | | shall be an ex-officio, nonvoting member and shall attend all | 6 | | meetings of the advisory council. Any member of the advisory | 7 | | council appointed under this Section may be a member General | 8 | | Assembly. Members shall receive no compensation for their | 9 | | services. | 10 | | (d) The Director of Public Health shall schedule the first | 11 | | meeting of the advisory council, which shall be held not later | 12 | | than 90 days after the effective date of this amendatory Act of | 13 | | the 99th General Assembly. A majority of the council members | 14 | | shall constitute a quorum. A majority vote of a quorum shall be | 15 | | required for any official action of the advisory council. The | 16 | | advisory council shall meet upon the call of the chairperson or | 17 | | upon the request of a majority of council members. | 18 | | (e) Not later than January 1, 2017, and annually | 19 | | thereafter, the advisory council shall issue a report to the | 20 | | General Assembly with recommendations concerning: | 21 | | (1) practice guidelines for the diagnosis and | 22 | | treatment of the disorder and syndrome; | 23 | | (2) mechanisms to increase clinical awareness and | 24 | | education regarding the disorder and syndrome among | 25 | | physicians, including pediatricians, school-based health | 26 | | centers, and providers of mental health services; |
| | | SB1684 Enrolled | - 5 - | LRB099 10340 JLK 30567 b |
|
| 1 | | (3) outreach to educators and parents to increase | 2 | | awareness of the disorder and syndrome; and | 3 | | (4) development of a network of volunteer experts on | 4 | | the diagnosis and treatment of the disorder and syndrome to | 5 | | assist in education and outreach. | 6 | | (20 ILCS 2310/2310-677 new) | 7 | | Sec. 2310-677. Neonatal Abstinence Syndrome Advisory | 8 | | Committee. | 9 | | (a) As used in this Section: | 10 | | "Department" means the Department of Public Health. | 11 | | "Director" means the Director of Public Health. | 12 | | "Neonatal Abstinence Syndrome" or "NAS" means various | 13 | | adverse conditions that occur in a newborn infant who was | 14 | | exposed to addictive or prescription drugs while in the | 15 | | mother's womb. | 16 | | (b) There is created the Advisory Committee on Neonatal | 17 | | Abstinence Syndrome. The Advisory Committee shall consist of up | 18 | | to 10 members appointed by the Director of Public Health. The | 19 | | Director shall make the appointments within 90 days after the | 20 | | effective date of this amendatory Act of the 99th General | 21 | | Assembly. Members shall receive no compensation for their | 22 | | services. The members of the Advisory Committee shall represent | 23 | | different racial, ethnic, and geographic backgrounds and | 24 | | consist of: | 25 | | (1) at least one member representing a statewide |
| | | SB1684 Enrolled | - 6 - | LRB099 10340 JLK 30567 b |
|
| 1 | | association of hospitals; | 2 | | (2) at least one member representing a statewide | 3 | | organization of pediatricians; | 4 | | (3) at least one member representing a statewide | 5 | | organization of obstetricians; | 6 | | (4) at least one member representing a statewide | 7 | | organization that advocates for the health of mothers and | 8 | | infants; | 9 | | (5) at least one member representing a statewide | 10 | | organization of licensed physicians; | 11 | | (6) at least one member who is a licensed practical | 12 | | nurse, registered professional nurse, or advanced practice | 13 | | nurse with expertise in the treatment of newborns in | 14 | | neonatal intensive care units; | 15 | | (7) at least one member representing a local or | 16 | | regional public health agency; and | 17 | | (8) at least one member with expertise in the treatment | 18 | | of drug dependency and addiction. | 19 | | (c) In addition to the membership in subsection (a) of this | 20 | | Section, the following persons or their designees shall serve | 21 | | as ex officio members of the Advisory Committee: the Director | 22 | | of Public Health, the Secretary of Human Services, the Director | 23 | | of Healthcare and Family Services, and the Director of Children | 24 | | and Family Services. The Director of Public Health, or his or | 25 | | her designee, shall serve as Chair of the Committee. | 26 | | (d) The Advisory Committee shall meet at the call of the |
| | | SB1684 Enrolled | - 7 - | LRB099 10340 JLK 30567 b |
|
| 1 | | Chair. The Committee shall meet at least 3 times each year and | 2 | | its initial meeting shall take place within 120 days after the | 3 | | effective date of this Act. The Advisory Committee shall advise | 4 | | and assist the Department to: | 5 | | (1) develop an appropriate standard clinical | 6 | | definition of "NAS"; | 7 | | (2) develop a uniform process of identifying NAS; | 8 | | (3) develop protocols for training hospital personnel | 9 | | in implementing an appropriate and uniform process for | 10 | | identifying and treating NAS; | 11 | | (4) identify and develop options for reporting NAS data | 12 | | to the Department by using existing or new data reporting | 13 | | options; and | 14 | | (5) make recommendations to the Department on | 15 | | evidence-based guidelines and programs to improve the | 16 | | outcomes of pregnancies with respect to NAS. | 17 | | (e) The Advisory Committee shall provide an annual report | 18 | | of its activities and recommendations to the Director, the | 19 | | General Assembly, and the Governor by March 31 of each year | 20 | | beginning in 2016. The final report of the Advisory Committee | 21 | | shall be submitted by March 31, 2019. | 22 | | (f) This Section is repealed on June 30, 2019. | 23 | | Section 99. Effective date. This Act takes effect upon | 24 | | becoming law.
|
|